Home/Neuropeutics/Ivan Makushenko, MEc, CFA, EMBA
IM

Ivan Makushenko, MEc, CFA, EMBA

Financial Strategist

Neuropeutics

Neuropeutics Pipeline

DrugIndicationPhase
JRMS-22Amyotrophic Lateral Sclerosis (ALS)Preclinical